Abnormal axonal development and severe epileptic phenotype in Dynamin‐1 ( DNM1 ) encephalopathy
Epileptic Disorders · 2024-02 · 26 (1) · 139-143
DOI: 10.1002/epd2.20181 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Epileptic Disorders, online erschienen am 02.12.2023. Verfasst von Kohei Matsubara und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology, Osaka City General Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Epilepsy, Brain Diseases, Spasms, Infantile. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Dynamin‐1 (DNM1) is involved in synaptic vesicle recycling, and DNM1 mutations can lead to developmental and epileptic encephalopathy. The neuroimaging of DNM1 encephalopathy has not been reported in detail. We describe a severe phenotype of DNM1 encephalopathy showing characteristic neuroradiological features. In addition, we reviewed previously reported cases who have DNM1 pathogenic variants with white matter abnormalities. Our case presented drug‐resistant seizures from 1 month of age and epileptic spasms at 2 years of age. Brain MRI showed no progression of myelination, progression of diffuse cerebral atrophy, and a thin corpus callosum. Proton magnetic resonance spectroscopy showed a decreased N‐acetylaspartate peak and diffusion tensor imaging presented with less pyramidal decussation. Whole‐exome sequencing revealed a recurrent de novo heterozygous variant of DNM1 . So far, more than 50 cases of DNM1 encephalopathy have been reported. Among these patients, delayed myelination occurred in two cases of GTPase‐domain DNM1 encephalopathy and in six cases of middle‐domain DNM1 encephalopathy. The neuroimaging findings in this case suggest inadequate axonal development. DNM1 is involved in the release of synaptic vesicles with the inhibitory transmitter GABA, suggesting that GABAergic neuron dysfunction is the mechanism of refractory epilepsy in DNM1 encephalopathy. GABA‐mediated signaling mechanisms play important roles in axonal development and GABAergic neuron dysfunction may be cause of white matter abnormalities in DNM1 encephalopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Neurology, Osaka City General Hospital, Osaka, Japan.
- Division of Medical Genetics, Osaka Women's and Children's Hospital, Osaka, Japan.
- Division of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
ORCID-Profile: Kohei Matsubara, Naoki Yamada, Masataka Fukuoka, Naomichi Matsumoto
Zitieren
APA
Matsubara, K., Kuki, I., Ishioka, R., Yamada, N., Fukuoka, M., Inoue, T., Nukui, M., Okamoto, N., Mizuguchi, T., Matsumoto, N., & Okazaki, S. (2024). Abnormal axonal development and severe epileptic phenotype in Dynamin‐1 ( DNM1 ) encephalopathy. Epileptic Disorders, 26(1), 139-143. https://doi.org/10.1002/epd2.20181
Vancouver
Matsubara K, Kuki I, Ishioka R, Yamada N, Fukuoka M, Inoue T, et al. Abnormal axonal development and severe epileptic phenotype in Dynamin‐1 ( DNM1 ) encephalopathy. Epileptic Disorders. 2024;26(1):139-143. doi:10.1002/epd2.20181
BibTeX
@article{Matsubara2024,
author = {Matsubara, Kohei and Kuki, Ichiro and Ishioka, Risako and Yamada, Naoki and Fukuoka, Masataka and Inoue, Takeshi and Nukui, Megumi and Okamoto, Nobuhiko and Mizuguchi, Takeshi and Matsumoto, Naomichi and Okazaki, Shin},
title = {Abnormal axonal development and severe epileptic phenotype in Dynamin‐1 ( DNM1 ) encephalopathy},
journal = {Epileptic Disorders},
year = {2024},
volume = {26},
number = {1},
pages = {139--143},
doi = {10.1002/epd2.20181}
}
EUVIMED